Marshall Wace’s CalciMedica CALC Stock Holding History

Marshall Wace’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,563	Closed	-$121K	–	2680
2021 Q1	$121K	Buy	+1,563	New	+$468K	﹤0.01%	2340

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

JJIJ

Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return

Marshall Wace's CALC Position: Q2 2021 in Review

Marshall Wace sold out of CalciMedica (CALC) in Q2 2021, closing a stake of 1,563 shares — an estimated $121K sold.

Marshall Wace first reported a position in CALC in Q1 2021 and held it in 1 quarter. The position peaked at $121K in Q1 2021. 41 funds tracked by Wall St. Rank hold CALC as of Q2 2021.

Marshall Wace reported no remaining CalciMedica position as of Q2 2021 after selling out during the quarter.
Marshall Wace sold 1,563 CalciMedica shares in Q2 2021, an estimated $121K.
Marshall Wace first reported a position in CalciMedica in Q1 2021 and held it in 1 quarter.
Marshall Wace's CalciMedica position peaked at $121K in Q1 2021.
41 funds tracked by Wall St. Rank held CalciMedica as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.